Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult Participants
Condition:   Healthy Interventions:   Drug: ALXN2050;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: MMF Sponsor:   Alexion Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2022 Category: Research Source Type: clinical trials